review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Stefan Pukatzki | |
Daniel Unterweger | |||
Sarah T Miyata | |||
Maya Kitaoka | |||
P2860 | cites work | DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae | Q22122394 |
P433 | issue | Pt 4 | |
P921 | main subject | Vibrio cholerae | Q160821 |
antibiotic resistance | Q380775 | ||
P304 | page(s) | 397-407 | |
P577 | publication date | 2011-01-20 | |
P1433 | published in | Journal of Medical Microbiology | Q15708716 |
P1476 | title | Antibiotic resistance mechanisms of Vibrio cholerae | |
P478 | volume | 60 |
Q53240866 | 3-Amino 1,8-naphthalimide, a structural analog of the anti-cholera drug virstatin inhibits chemically-biased swimming and swarming motility in vibrios. |
Q39839649 | A genomic island integrated into recA of Vibrio cholerae contains a divergent recA and provides multi-pathway protection from DNA damage |
Q52628040 | ATP-Binding Cassette Transporter VcaM from Vibrio cholerae is Dependent on the Outer Membrane Factor Family for Its Function. |
Q40768570 | An in silico, in vitro and in vivo investigation of indole-3-carboxaldehyde identified from the seawater bacterium Marinomonas sp. as an anti-biofilm agent against Vibrio cholerae O1. |
Q30371416 | Anethole inhibits growth of recently emerged multidrug resistant toxigenic Vibrio cholerae O1 El Tor variant strains in vitro. |
Q53685610 | Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against Vibrio spp. |
Q39617710 | Antibiotic resistance and plasmid profiling of Vibrio spp. in tropical waters of Peninsular Malaysia |
Q38632406 | Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. |
Q57929933 | Antimicrobial Susceptibility of Environmental Non-O1/Non-O139 Isolates |
Q38830043 | Antimicrobial peptides in marine invertebrate health and disease. |
Q60912063 | Antimicrobial resistance of from sub-Saharan Africa: A systematic review |
Q58689795 | Assessing the Impact of Increasing Antimicrobial Resistance of Vibrio cholerae on the Future Trends of Cholera Epidemic |
Q35933945 | Biochemistry of bacterial multidrug efflux pumps. |
Q49472665 | Bovine Lactoferrin and Lactoferrin-Derived Peptides Inhibit the Growth of Vibrio cholerae and Other Vibrio species |
Q92842417 | Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas |
Q92386402 | Capsaicin inhibitory effects on Vibrio cholerae toxin genes expression |
Q30397700 | Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand |
Q36969170 | Cholera outbreak caused by drug resistant Vibrio cholerae serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study |
Q35564879 | Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection |
Q30372172 | Comparative genome analysis of non-toxigenic non-O1 versus toxigenic O1 Vibrio cholerae. |
Q39288173 | Comparative genomics study for identification of drug and vaccine targets in Vibrio cholerae: MurA ligase as a case study |
Q54335468 | Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli. |
Q53460992 | Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT. |
Q91971632 | Confirmed and Potential Roles of Bacterial T6SSs in the Intestinal Ecosystem |
Q36290827 | Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity. |
Q33688967 | Cyclo(valine-valine) inhibits Vibrio cholerae virulence gene expression. |
Q90583429 | Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review |
Q35847243 | Drug-resistance mechanisms in Vibrio cholerae O1 outbreak strain, Haiti, 2010. |
Q45277848 | Dynamics analysis of a multi-strain cholera model with an imperfect vaccine. |
Q92688758 | Emergence of Azithromycin Resistance Mediated by Phosphotransferase-Encoding mph(A) in Diarrheagenic Vibrio fluvialis |
Q36528810 | Emergence of Tetracycline Resistant Vibrio cholerae O1 Biotype El Tor Serotype Ogawa with Classical ctxB Gene from a Cholera Outbreak in Odisha, Eastern India |
Q38073080 | Fitness factors in vibrios: a mini-review |
Q38419777 | Gastrointestinal infections in the setting of natural disasters |
Q92340042 | Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae |
Q35102858 | High-throughput screening and whole genome sequencing identifies an antimicrobially active inhibitor of Vibrio cholerae |
Q92705298 | Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes |
Q40117738 | Impact of Awareness Programs on Cholera Dynamics: Two Modeling Approaches |
Q48344840 | Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties. |
Q92296556 | Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: An assessment of existing data and a scoping review of the literature |
Q53340851 | Modulation of the multidrug efflux pump EmrD-3 from Vibrio cholerae by Allium sativum extract and the bioactive agent allyl sulfide plus synergistic enhancement of antimicrobial susceptibility by A. sativum extract. |
Q30428321 | Molecular analysis of non-O1/non-O139 Vibrio cholerae isolated from hospitalised patients in China |
Q34305626 | Multiple antibiotic resistance of Vibrio cholerae serogroup O139 in China from 1993 to 2009 |
Q47937884 | MurB as a target in an alternative approach to tackle the Vibrio cholerae resistance using molecular docking and simulation study |
Q36075834 | Non-O1/Non-O139 Vibrio cholerae Avian Isolate from France Cocarrying the bla(VIM-1) and bla(VIM-4) Genes. |
Q90261461 | Patterns of triclosan resistance in Vibrionaceae |
Q64081404 | Phage Endolysins as Potential Antimicrobials against Multidrug Resistant and : Current Status of Research and Challenges Ahead |
Q61856728 | Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal |
Q42920635 | Potential for inhibition of bacterial efflux pumps in multidrug-resistant Vibrio cholera |
Q36586658 | RND multidrug efflux pumps: what are they good for? |
Q30513891 | Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections |
Q57094470 | Redefinition and Unification of the SXT/R391 Family of Integrative and Conjugative Elements |
Q37345941 | Reduced Susceptibility to Extended-Spectrum β-Lactams in Vibrio cholerae Isolated in Bangladesh |
Q36683682 | Resistance to Antimicrobial Peptides in Vibrios |
Q28821326 | Selective and Efficient Elimination of Vibrio cholerae with a Chemical Modulator that Targets Glucose Metabolism |
Q42200260 | Structure based virtual screening of novel inhibitors against multidrug resistant superbugs |
Q92615774 | Synthesis, Characterization, Antibacterial Activity, and Computer-Aided Design of Novel Quinazolin-2,4-dione Derivatives as Potential Inhibitors Against Vibrio cholerae |
Q30360835 | The Vibrio cholerae type VI secretion system employs diverse effector modules for intraspecific competition. |
Q42716272 | The time of cholera |
Q26745647 | Therapeutic significance and pharmacological activities of antidiarrheal medicinal plants mention in Ayurveda: A review |
Q41921695 | Vibrio Pathogens: A Public Health Concern in Rural Water Resources in Sub-Saharan Africa |
Q37653719 | Vibrio cholerae O1 with Reduced Susceptibility to Ciprofloxacin and Azithromycin Isolated from a Rural Coastal Area of Bangladesh |
Q92037491 | Virulence, antimicrobial and heavy metal tolerance, and genetic diversity of Vibrio cholerae recovered from commonly consumed freshwater fish |
Q30367272 | Worldwide occurrence of integrative conjugative element encoding multidrug resistance determinants in epidemic Vibrio cholerae O1. |
Q40061810 | Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor |
Search more.